Views: 0 Author: Site Editor A chhuah hun: 2026-09-22 A chhuahna: Hmun
Distributor, brand neitu, leh private-label operator ruahmanna siamtute tan a compressor nebulizer program, specification sheet te hi a inang tlangpui — figure pakhat check a nih hma loh chuan: aerosol particle size. Unit pahnih chu rintlak takin an tlan thei a, hmuh theih mist an siam thei a, test apiang an paltlang thei a, chutih rualin dose tam zawk chu prescription target-in bronchi emaw alveoli emaw-ah ni lovin hmui leh kawchhungah an la pe chhuak thei tho. Chu gap chu channel feedback chak lo, complaint rate sang zawk, leh man nghet lo angin a lang.
Lei duh tan chuan aerosol particle size hi footnote a ni lo. OEM/ODM program commit hmaa chhiar, tehkhin leh finfiah ngai specification a ni.
Lung branching structure hian natural aerodynamic filter angin hna a thawk a: target a thuk poh leh particle chu a te zawk a ngai a ni.
5 μm vel aia lian particle te chu oropharynx leh upper airways-ah an awm a, chutah chuan an insiam a, an ei a, an ei a;
particle roughly 2–5 μm te hi thawkna kawng hnuai lam leh bronchi — asthma leh COPD enkawlna atana target zone-ah a tha hle a;
particle 1–2 μm vel chu alveolar region an thleng a;
0.5–1 μm vel hnuai lam particle te chu a tam zawk chu an deposit hmain an thawk chhuak thin.
Chuvangin standards framework chuan particle size chu primary performance characteristic atan a ngai a ni. ISO 27427 (Output rate atan Annex C, particle size distribution atan Annex D) hnuaiah chuan thil siamtute chuan output rate leh residual volume bakah distribution — a tlangpuiin MMAD leh respirable fraction angin — an puan chhuah beisei a ni.
MMAD hi aerodynamic diameter a ni a, chutah chuan aerosol mass 50% chu chutiang size emaw a aia te emaw droplet-ah a awm a ni. Aerodynamic — geometric ni lovin — diameter hi tehna dik tak a ni a, a chhan chu a size leh density pahnih a account a ni. Lower-airway therapy atan chuan 1–5 μm band-a MMAD hi clinically useful range a ni a, compressor system tha tak tak tan chuan roughly 2–4 μm vel report a ni tlangpui.
MMAD chauh hian a hruai sual thei: distribution pakhat chu 3 μm-ah a thu thei a, a mass tam zawk chu 5 μm aia sangah a dah thei bawk. Respirable fraction — aerosol mass 5 μm hnuai lam cumulative percentage — chuan gap chu a khar a ni. Emitted dose engzat nge lower airways thleng thei range-ah a awm tih a tarlang a ni.
GSD hian median vel a distribution cluster te chu engtiang chiahin nge a tight tih a sawifiah a. ISO 27427 testing hian GSD nena MMAD a report tlangpui a, specification-ah chuan GSD ≤ 2.0 a target fo bawk.
Residual volume chu nebulization a tawp huna damdawi cup chhunga tui awm zat a ni. Particle size a tidanglam lo va, mahse a dose pek zat chu engtikah nge aerosol a lo nih tih erawh a thlak danglam thung. Residual volume sang chuan ngawi rengin delivered dose a tihtlem a, enkawlna hun a ti rei bawk — damlote chuan 'the machine never finishes' angin an hria a, channel-te chuan accessory leh complaint volume angin an hre bawk.
Aerodynamic particle lian leh te |
Primary deposition awmna hmun a ni |
Therapeutic nena inzawmna nei |
>5 μm a ni |
Oropharynx, thawkna kawng chunglam |
A tam zawk chu ei emaw, tihfai emaw; lung hlawkna tlem |
2–5 μm a ni |
Thlipui hnuai lam, bronchi |
Asthma leh COPD therapy atana target zone |
1–2 μm a ni |
Alveolar bial a ni |
Deep-lung delivery atan a tha hle |
<0.5–1 μm a ni |
Exhalation hmanga tihkhawtlai |
Share lian tak chu deposit hmain exhaled |
Practical reading chu a awlsam hle: nebulizer hna chu mist siam a ni lo va, 1–5 μm band-a mass dah a ni. Thil dang zawng zawng hi target thleng ngai lo emitted dose a ni.
Jet leh venturi geometry — median size-a lever hmasa ber.
Baffle design — coarse spray chu thawk thei distribution ah a chantir.
Compressor airflow leh pressure — output rate leh particle size hi a kal dun a, chuvangin pump leh cup hi matched pair anga validate a ngai a ni.
Cup design leh fill volume — ISO 27427 figure te hi stated fill volume leh breathing profile ah an inzawm a ni.
Drug formulation — suspensions hian undissolved particles a keng tel a, a size hian distribution a thunun thei a ni.
Operating mode — continuous versus breath-actuated designs hian nominal specification inang atanga effective dose hrang hrang a pe chhuak thin.
Supplier pahnih chuan 'MMAD ≤ 5 μm' an claim thei ve ve a, damdawi hrang hrang hmangin fill volume hrang hrangah awmze nei takin respirable fraction hrang hrang an la pe chhuak thei tho. Specification hi test conditions te number kianga tarlan a nih chauhvin tehkhin theih a ni.
Channel / Segment hrang hrangah a awm |
Aerosol specification hi eng atan nge hman a nih |
Hospital leh clinical tender te pawh a awm bawk |
Dan zawm dan finfiahna; MMAD, respirable fraction leh bidding atana test condition mamawh te a ni |
Pharmacy leh professional recommendation te pawh a awm bawk |
Recommendation-a inrintawkna nei; documentation hian in-store counseling a thlawp a ni |
Distributor portfolio hrang hrang a awm bawk |
Packaging leh listing page-a performance claims te; category hrang hranga inthliarna |
Private-label / brand neitu programme hrang hrang a awm bawk |
Defensible marketing claims te chu; inelna neitute tehkhin thu dik lo laka venhimna |
Naupang leh in lama thawkna lam enkawlna |
Enkawl hun, tuar theih leh zawm dan; accessory leh repeat-purchase economics te a ni |
Joytech Healthcare hian ram 150 chuangah thawn chhuah tawh compressor-focused core aṭangin khawvel pum huapa sem chhuah theih turin home healthcare devices a siam ṭhin. Compressor nebulizer range — NB series huam chhunga puitling, naupang, portable, leh themed SKU te huamtu — hi OEM/ODM program structure chhungah a thu a, hei hian distributor leh brand partner-te tana branding, packaging, leh configuration te a thlawp a ni.
Commercial case-a tel ve tura aerosol performance mamawh lei duhtute tan Joytech chuan:
l ISO 13485 hnuaia compressor nebulizer siam a ni a, documented process control hmangin, medical-grade component leh BPA-free material hmanga siam a ni
l Particle size distribution huam chhunga internal testing theihna, EMC, electrical safety, leh usability evaluation te nen
l Compressor pump leh medication cup te chu matched system anga validation a nih avangin output rate leh particle distribution te chu independent a ni lovin a inzawm khawm a optimize a ni
l Certification coverage-ah hian CE MDR (EU 2017/745), Canada Medical Device Licence, leh MHRA registration te pawh a tel a, model thlan bikte chuan FDA 510(k) clearance an keng tel bawk
l R&D specialist 100+ zetin specification alignment leh regulatory documentation an thlawp
l A pum puia accessory ecosystem pakhat nebulizer kits — damdawi cup, puitling / naupang / nausen hmai tuamna, hmui khuhna, leh air tubing te
l Manufacturing footprint 260,000+ sqm huam chhunga production, patent 100+ hmanga thlawp
Respiratory care hian documented zawk, regulated zawk, leh professionalized channel structure lam a pan chhoh zel chuan, an dinhmun chelh tlattu product te chu an aerosol performance chu a lan dan atanga lantir ai chuan sawi theih te an ni ang. Aerosol particle size hi specification a ni a, chu chu finfiah theih, tehkhin theih leh defensible product claim-a siam theih a ni — mahse, manufacturer-in a teh a, a document a, a result chu production scale-ah a repeat thei chauh a ni.
Nebulizer OEM/ODM program chungchang sawiho duh tan, category documentation dil duh tan, emaw technical evaluation sample ruahman duh tan biak theih reng a ni sale14@sejoy.com.
Asthma leh COPD management ang chi lower-airway therapy atan chuan 1–5 μm inkar MMAD chu clinically useful band anga ngaih a ni tlangpui a, compressor system tha tak tak tan chuan 2–4 μm vel report a ni tlangpui. MMAD hi respirable fraction leh GSD nen pair rawh — median chauh hian dose engzat nge a tangkai tak tak tih a tarlang lo.
MMAD hian distribution lai tak chu khawiah nge a thu tih a sawi a, dose engzat nge a tangkai tih a sawi lo. Respirable fraction hian emitted aerosol mass proportion 5 μm hnuai lam a pe a — chu chu thawkna kawng hnuai lam thleng thei portion a ni. MMAD figure inang nei nebulizer pahnih chu respirable fraction-ah nasa takin a danglam thei a, chu danglamna chu delivered dose leh clinical response-ah a letling a ni.
Awle. Distribution leh output rate hi stated fill volume leh breathing profile hmanga teh a ni a, fill volume danga performance chu automatic-in a inang lo. Suspension hian undissolved particle a keng tel a, a size hian solution aiin distribution a nghawng danglam a ni. Supplier te chu fill volume, test drug, leh test method tarlan nen chauh khaikhin rawh.